アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/04/13 | 2,011 | 2,089 | 2,004.5 | 2,076.5 | +52 | +2.6% | 7,250,900 |
2022/04/12 | 2,073.5 | 2,076.5 | 2,011.5 | 2,024.5 | -76 | -3.6% | 6,672,900 |
2022/04/11 | 1,996 | 2,105 | 1,990.5 | 2,100.5 | +104.5 | +5.2% | 10,340,800 |
2022/04/08 | 2,038 | 2,063.5 | 1,981.5 | 1,996 | -12 | -0.6% | 10,077,800 |
2022/04/07 | 1,947.5 | 2,014 | 1,926 | 2,008 | +110 | +5.8% | 10,697,500 |
2022/04/06 | 1,881.5 | 1,906.5 | 1,872.5 | 1,898 | +22.5 | +1.2% | 5,311,600 |
2022/04/05 | 1,860 | 1,891 | 1,860 | 1,875.5 | -50.5 | -2.6% | 5,614,700 |
2022/04/04 | 1,885.5 | 1,935 | 1,875 | 1,926 | +72 | +3.9% | 5,559,300 |
2022/04/01 | 1,898.5 | 1,901.5 | 1,854 | 1,854 | -57 | -3% | 6,377,200 |
2022/03/31 | 1,937.5 | 1,950 | 1,909 | 1,911 | -42.5 | -2.2% | 6,009,100 |
2022/03/30 | 1,961 | 1,974 | 1,929.5 | 1,953.5 | -16 | -0.8% | 4,208,900 |
2022/03/29 | 1,964 | 1,979.5 | 1,949.5 | 1,969.5 | +24.5 | +1.3% | 5,393,400 |
2022/03/28 | 1,962 | 1,964.5 | 1,941 | 1,945 | -16 | -0.8% | 3,274,000 |
2022/03/25 | 1,975 | 1,977 | 1,941 | 1,961 | -10.5 | -0.5% | 3,621,000 |
2022/03/24 | 1,979 | 1,985 | 1,939.5 | 1,971.5 | -27 | -1.4% | 4,350,600 |
2022/03/23 | 1,971 | 2,002 | 1,968.5 | 1,998.5 | +53 | +2.7% | 4,059,300 |
2022/03/22 | 1,910 | 1,945.5 | 1,910 | 1,945.5 | +35.5 | +1.9% | 5,230,600 |
2022/03/18 | 1,919 | 1,919 | 1,881 | 1,910 | -1 | -0.1% | 6,937,100 |
2022/03/17 | 1,910 | 1,912 | 1,870.5 | 1,911 | +36.5 | +1.9% | 5,821,700 |
2022/03/16 | 1,872.5 | 1,887.5 | 1,863.5 | 1,874.5 | +23.5 | +1.3% | 6,570,200 |
2022/03/15 | 1,865 | 1,865 | 1,782 | 1,851 | -41.5 | -2.2% | 8,377,000 |
2022/03/14 | 1,885.5 | 1,930.5 | 1,875 | 1,892.5 | +47 | +2.5% | 5,621,800 |
2022/03/11 | 1,823 | 1,864.5 | 1,820.5 | 1,845.5 | +20 | +1.1% | 7,345,600 |
2022/03/10 | 1,797 | 1,828 | 1,786.5 | 1,825.5 | +26.5 | +1.5% | 7,706,900 |
2022/03/09 | 1,843 | 1,850 | 1,796 | 1,799 | -59 | -3.2% | 7,895,300 |
2022/03/08 | 1,869.5 | 1,894.5 | 1,843.5 | 1,858 | +13 | +0.7% | 8,661,800 |
2022/03/07 | 1,805.5 | 1,854 | 1,801 | 1,845 | +13.5 | +0.7% | 7,330,300 |
2022/03/04 | 1,880.5 | 1,881.5 | 1,829 | 1,831.5 | -49.5 | -2.6% | 7,764,500 |
2022/03/03 | 1,882.5 | 1,894.5 | 1,872 | 1,881 | +19 | +1% | 7,612,100 |
2022/03/02 | 1,908 | 1,919 | 1,846 | 1,862 | -46.5 | -2.4% | 8,289,500 |
2022/03/01 | 1,900 | 1,924.5 | 1,900 | 1,908.5 | -10 | -0.5% | 9,105,800 |
2022/02/28 | 1,911 | 1,938 | 1,906 | 1,918.5 | -4 | -0.2% | 7,128,000 |
2022/02/25 | 1,925 | 1,946.5 | 1,906 | 1,922.5 | +0.5 | ±0% | 6,808,600 |
2022/02/24 | 1,934 | 1,937 | 1,908 | 1,922 | -77.5 | -3.9% | 9,993,300 |
2022/02/22 | 1,990.5 | 2,010.5 | 1,969 | 1,999.5 | +9 | +0.5% | 4,897,900 |
2022/02/21 | 1,983 | 1,999 | 1,977 | 1,990.5 | -1 | -0.1% | 3,639,800 |
2022/02/18 | 1,985.5 | 2,005.5 | 1,985.5 | 1,991.5 | -26.5 | -1.3% | 5,256,500 |
2022/02/17 | 2,025 | 2,044.5 | 2,008.5 | 2,018 | +4 | +0.2% | 4,832,900 |
2022/02/16 | 1,999.5 | 2,024 | 1,994.5 | 2,014 | +42.5 | +2.2% | 4,495,900 |
2022/02/15 | 1,983.5 | 2,008 | 1,961 | 1,971.5 | -12 | -0.6% | 5,133,700 |
2022/02/14 | 1,981.5 | 1,994.5 | 1,952 | 1,983.5 | -45.5 | -2.2% | 6,587,300 |
2022/02/10 | 2,027.5 | 2,042 | 2,013.5 | 2,029 | +1.5 | +0.1% | 7,076,600 |
2022/02/09 | 2,031.5 | 2,042 | 2,006 | 2,027.5 | -18.5 | -0.9% | 6,101,400 |
2022/02/08 | 2,017 | 2,052 | 2,013 | 2,046 | +24.5 | +1.2% | 5,569,900 |
2022/02/07 | 1,983 | 2,028 | 1,982.5 | 2,021.5 | +22 | +1.1% | 5,282,600 |
2022/02/04 | 1,949 | 2,008 | 1,946.5 | 1,999.5 | +27.5 | +1.4% | 6,334,700 |
2022/02/03 | 1,946 | 1,976 | 1,907.5 | 1,972 | +26 | +1.3% | 7,315,900 |
2022/02/02 | 1,857.5 | 1,955 | 1,855 | 1,946 | +84.5 | +4.5% | 6,826,100 |
2022/02/01 | 1,825 | 1,877.5 | 1,823.5 | 1,861.5 | +11 | +0.6% | 4,581,200 |
2022/01/31 | 1,870.5 | 1,872 | 1,824.5 | 1,850.5 | -30 | -1.6% | 4,924,300 |
751~
800
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム